Pig Virus Concern for Solvay Pharmaceuticals, Inc. Enzyme Says FDA

December 1, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WASHINGTON, Nov 28 (Reuters) - U.S. health regulators are concerned about the risk of patients contracting viruses from pig glands used to make Solvay Pharmaceuticals Inc's pancreatic enzyme product Creon, according to documents released on Friday.

Twitter
LinkedIn
Facebook
Email
Print

Food and Drug Administration (FDA)